Arbor, Lupin End IP Suit Over Planned Blood Pressure Generic
A Delaware federal judge has signed off on the joint dismissal of a patent infringement suit brought by Arbor Pharmaceuticals and Takeda Pharmaceutical Co., the makers of blood pressure drug Edarbi,...To view the full article, register now.
Already a subscriber? Click here to view full article